- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/50 - Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
Patent holdings for IPC class A61K 38/50
Total number of patents in this class: 690
10-year publication summary
|
37
|
56
|
68
|
64
|
69
|
81
|
54
|
46
|
48
|
39
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theriva Biologics, Inc. | 88 |
44 |
| Beam Therapeutics Inc. | 296 |
18 |
| President and Fellows of Harvard College | 6110 |
17 |
| Icahn School of Medicine at Mount Sinai | 1048 |
17 |
| Polaris Group | 20 |
16 |
| Jazz Pharmaceuticals Ireland Limited | 173 |
15 |
| University of Massachusetts | 2329 |
15 |
| The Regents of the University of California | 20842 |
12 |
| The Trustees of the University of Pennsylvania | 4432 |
10 |
| Thornhill Therapeutics, Inc. | 33 |
10 |
| Erytech Pharma | 48 |
9 |
| Kyon Biotech AG | 24 |
9 |
| California Institute of Technology | 4037 |
8 |
| AERase, Inc. | 12 |
7 |
| The Rockefeller University | 582 |
7 |
| Synthetic Biologics, Inc. | 29 |
7 |
| Translate bio, Inc. | 415 |
7 |
| The Broad Institute, Inc. | 1990 |
6 |
| Rowan University | 196 |
6 |
| The Trustees of Indiana University | 836 |
6 |
| Other owners | 444 |